Tal Schechter - Concepedia

Author

Tal Schechter

Hospital for Sick Children ORCID

Also Known As

Schechter, Tal, T SCHECHTER, T Schechter, T. SCHECHTER, T. Schechter, Tal Schechter

205

Publications

3.9K

Citations

H-Index

Concepts

All Affiliations

Hospital for Sick Children University of Toronto SickKids Foundation University of Pennsylvania Institute for Clinical Evaluative Sciences

About

Tal Schechter is an author at Hospital for Sick Children specializing in medicine, hematology, and pediatrics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	26	654
2	Health Sciences	7	7	171
3	Public Health	3	3	51
4	Social Sciences	1	1	28
5	Allergy	1	1	13

Tal Schechter

Publications

3.2K

Citations

H-Index

Page 1

	Year	Citations
International, Multicenter Standardization of Acute Graft-versus-Host Disease Clinical Data Collection: A Report from the Mount Sinai Acute GVHD International Consortium Andrew C. Harris, Rachel Young, Steven M. Devine, Biology of Blood and Marrow Transplantation	2015	882
Outcomes by Clinical and Molecular Features in Children With Medulloblastoma Treated With Risk-Adapted Therapy: Results of an International Phase III Trial (SJMB03) Amar Gajjar, Giles Robinson, Kyle Smith, Journal of Clinical Oncology	2021	217
Children's Oncology Group Trial AALL1231: A Phase III Clinical Trial Testing Bortezomib in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia and Lymphoma David T. Teachey, Meenakshi Devidas, Brent L. Wood, Journal of Clinical Oncology	2022	137
The MAGIC algorithm probability is a validated response biomarker of treatment of acute graft-versus-host disease Hrishikesh K. Srinagesh, Umut Özbek, Urvi Kapoor, Blood Advances	2019	105
Benefits and challenges with diagnosing chronic and late acute GVHD in children using the NIH consensus criteria Geoff D.E. Cuvelier, Eneida R. Nemecek, Justin T. Wahlstrom, Blood	2019	87
Immune profile differences between chronic GVHD and late acute GVHD: results of the ABLE/PBMTC 1202 studies Kirk R. Schultz, Amina Kariminia, Bernard Ng, Blood	2020	64
A pilot study to evaluate the feasibility of individualized yoga for inpatient children receiving intensive chemotherapy Caroline Diorio, Tal Schechter, Michelle Lee, BMC Complementary and Alternative Medicine	2015	61
Pharmacokinetic Disposition and Clinical Outcomes in Infants and Children Receiving Intravenous Busulfan for Allogeneic Hematopoietic Stem Cell Transplantation Tal Schechter, Yaron Finkelstein, John Doyle, Biology of Blood and Marrow Transplantation	2007	61
Significant Transplantation-Related Mortality from Respiratory Virus Infections within the First One Hundred Days in Children after Hematopoietic Stem Cell Transplantation Sakara Hutspardol, Mohammed Al Essa, Susan E. Richardson, Biology of Blood and Marrow Transplantation	2015	60
Unfractionated heparin dosing in young infants: clinical outcomes in a cohort monitored with anti‐factor Xa levels Tal Schechter, Yaron Finkelstein, Mona A. Ali, Journal of Thrombosis and Haemostasis Young InfantsClinical EpidemiologyPediatricsAnti‐factor Xa LevelsNewborn Medicine	2012	58

Page 1